Literature DB >> 17925544

Interpreting P values in pharmacogenetic studies: a call for process and perspective.

Michael L Maitland, Mark J Ratain, Nancy J Cox.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17925544     DOI： 10.1200/JCO.2007.12.7803

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  12 in total

1.  Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741.

Authors:  Howard L McLeod; Daniel J Sargent; Sharon Marsh; Erin M Green; Cristi R King; Charles S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Stephen N Thibodeau; Axel Grothey; Roscoe F Morton; Richard M Goldberg
Journal:  J Clin Oncol       Date:  2010-06-07       Impact factor: 44.544

Review 2.  Pediatric pharmacogenetic and pharmacogenomic studies: the current state and future perspectives.

Authors:  Roberta Russo; Mario Capasso; Paolo Paolucci; Achille Iolascon
Journal:  Eur J Clin Pharmacol       Date:  2010-11-11       Impact factor: 2.953

Review 3.  Implications of genome-wide association studies in cancer therapeutics.

Authors:  Jai N Patel; Howard L McLeod; Federico Innocenti
Journal:  Br J Clin Pharmacol       Date:  2013-09       Impact factor: 4.335

Review 4.  Pharmacogenomics in early-phase oncology clinical trials: is there a sweet spot in phase II?

Authors:  Peter H O'Donnell; Walter M Stadler
Journal:  Clin Cancer Res       Date:  2012-03-16       Impact factor: 12.531

5.  Clinical trials in the era of personalized oncology.

Authors:  Michael L Maitland; Richard L Schilsky
Journal:  CA Cancer J Clin       Date:  2011-10-27       Impact factor: 508.702

6.  Population differences in platinum toxicity as a means to identify novel genetic susceptibility variants.

Authors:  Peter H O'Donnell; Eric Gamazon; Wei Zhang; Amy L Stark; Emily O Kistner-Griffin; R Stephanie Huang; M Eileen Dolan
Journal:  Pharmacogenet Genomics       Date:  2010-05       Impact factor: 2.089

7.  Retrospective study of the impact of pharmacogenetic variants on paclitaxel toxicity and survival in patients with ovarian cancer.

Authors:  Troels K Bergmann; Henrik Gréen; Charlotte Brasch-Andersen; Mansoor R Mirza; Jørn Herrstedt; Berit Hølund; Andreas du Bois; Per Damkier; Werner Vach; Kim Brosen; Curt Peterson
Journal:  Eur J Clin Pharmacol       Date:  2011-02-16       Impact factor: 2.953

Review 8.  Cancer pharmacoethnicity: ethnic differences in susceptibility to the effects of chemotherapy.

Authors:  Peter H O'Donnell; M Eileen Dolan
Journal:  Clin Cancer Res       Date:  2009-07-21       Impact factor: 12.531

Review 9.  Biomarker in Colorectal Cancer.

Authors:  Marta Schirripa; Heinz-Josef Lenz
Journal:  Cancer J       Date:  2016 May-Jun       Impact factor: 3.360

10.  Genome-wide association studies in pharmacogenomics: untapped potential for translation.

Authors:  Idris Guessous; Marta Gwinn; Muin J Khoury
Journal:  Genome Med       Date:  2009-04-28       Impact factor: 11.117
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.